|
1
|
Chua ML, Wee JT, Hui EP and Chan AT:
Nasopharyngeal carcinoma. Lancet. 387:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee AW, Sze WM, Au JS, Leung SF, Leung TW,
Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al: Treatment results
for nasopharyngeal carcinoma in the modern era: The Hong Kong
experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zackrisson B, Mercke C, Strander H,
Wennerberg J and Cavallin-Ståhl E: A systematic overview of
radiation therapy effects in head and neck cancer. Acta Oncol.
42:443–461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chua D, Huang J, Zheng B, Lau SY, Luk W,
Kwong DL, Sham JS, Moss D, Yuen KY, Im SW and Ng MH: Adoptive
transfer of autologous Epstein-Barr virus-specific cytotoxic T
cells for nasopharyngeal carcinoma. Int J Cancer. 94:73–80. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Comoli P, Pedrazzoli P, Maccario R, Basso
S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C,
Perotti C, et al: Cell therapy of stage IV nasopharyngeal carcinoma
with autologous Epstein-Barr virus-targeted cytotoxic T
lymphocytes. J Clin Oncol. 23:8942–8949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin CL, Lo WF, Lee TH, Ren Y, Hwang SL,
Cheng YF, Chen CL, Chang YS, Lee SP, Rickinson AB and Tam PK:
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic
cells induces functional CD8+ T-cell immunity and may
lead to tumor regression in patients with EBV-positive
nasopharyngeal carcinoma. Cancer Res. 62:6952–6958. 2002.PubMed/NCBI
|
|
7
|
Smith C, Tsang J, Beagley L, Chua D, Lee
V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, et al: Effective
treatment of metastatic forms of Epstein-Barr virus-associated
nasopharyngeal carcinoma with a novel adenovirus-based adoptive
immunotherapy. Cancer Res. 72:1116–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collin M and Haniffa M: Dendritic cells
and dendritic cell subsets. Encyclopedia of Immunobiology. Academic
Press; Oxford: pp. 345–352. 2016, View Article : Google Scholar
|
|
9
|
Lundberg K, Rydnert F, Greiff L and
Lindstedt M: Human blood dendritic cell subsets exhibit
discriminative pattern recognition receptor profiles. Immunology.
142:279–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Joffre OP, Segura E, Savina A and
Amigorena S: Cross-presentation by dendritic cells. Nat Rev
Immunol. 12:557–569. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valladeau J, Ravel O, Dezutter-Dambuyant
C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C,
Schmitt D, Davoust J, et al: Langerin, a novel C-type lectin
specific to Langerhans cells, is an endocytic receptor that induces
the formation of Birbeck granules. Immunity. 12:71–81. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Idoyaga J, Cheong C, Suda K, Suda N, Kim
JY, Lee H, Park CG and Steinman RM: Cutting edge: Langerin/CD207
receptor on dendritic cells mediates efficient antigen presentation
on MHC I and II products in vivo. J Immunol. 180:3647–3650. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thomas JA, Iliescu V, Crawford DH, Ellouz
R, Cammoun M and de-Thé G: Expression of HLA-DR antigens in
nasopharyngeal carcinoma: An immunohistological analysis of the
tumour cells and infiltrating lymphocytes. Int J Cancer.
33:813–819. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braz-Silva PH, Vitale S, Butori C, Guevara
N, Santini J, Magalhaes M, Hofman P and Doglio A: Specific
infiltration of langerin-positive dendritic cells in EBV-infected
tonsil, Hodgkin lymphoma and nasopharyngeal carcinoma. Int J
Cancer. 128:2501–2508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hammar S, Bockus D, Remington F and Bartha
M: The widespread distribution of Langerhans cells in pathologic
tissues: An ultrastructural and immunohistochemical study. Hum
Pathol. 17:894–905. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lauriola L, Michetti F, Sentinelli S and
Cocchia D: Detection of S-100 labelled cells in nasopharyngeal
carcinoma. J Clin Pathol. 37:1235–1238. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma CX, Jia TC, Li XR, Zhand ZF and Yiao
CB: Langerhans cells in nasopharyngeal carcinoma in relation to
prognosis. In Vivo. 9:225–229. 1995.PubMed/NCBI
|
|
18
|
Zong YS, Zhang CQ, Zhang F, Ruan JB, Chen
MY, Feng KT and Yu ZF: Infiltrating lymphocytes and accessory cells
in nasopharyngeal carcinoma. Jpn J Cancer Res. 84:900–905. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson LD: Update on nasopharyngeal
carcinoma. Head Neck Pathol. 1:81–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH, Gospodarowicz MK and Wittekind
C: UICC: TNM Classification of Malignant Tumours. 7th.
Wiley-Blackwell; New Jersey: 2009
|
|
21
|
Segura E, Durand M and Amigorena S:
Similar antigen cross-presentation capacity and phagocytic
functions in all freshly isolated human lymphoid organ-resident
dendritic cells. J Exp Med. 210:1035–1047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang CS, Chang JH, Hsu NC, Lin HY and
Chung CY: Expression of CD80 and CD86 costimulatory molecules are
potential markers for better survival in nasopharyngeal carcinoma.
BMC Cancer. 7:882007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin W, Duluc D, Joo H and Oh S: Dendritic
cell targeting vaccine for HPV-associated cancer. Cancer Cell
Microenviron. 3:e14822016.PubMed/NCBI
|
|
24
|
Villani AC, Satija R, Reynolds G,
Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S,
Lazo S, et al: Single-cell RNA-seq reveals new types of human blood
dendritic cells, monocytes, and progenitors. Science. 356(pii):
eaah45732017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abolhalaj M, Askmyr D, Sakellariou CA,
Lundberg K, Greiff L and Lindstedt M: Profiling dendritic cell
subsets in head and neck squamous cell tonsillar cancer and benign
tonsils. Sci Rep. 8:80302018. View Article : Google Scholar : PubMed/NCBI
|
